{
  "id": "medicine--medical-ethics--t-drug-pricing-ethics",
  "version": 1,
  "subject": "Medicine",
  "subcategory": "Medical Ethics",
  "course_id": "medicine--medical-ethics",
  "chapter_id": "medicine--medical-ethics--ch05-justice-and-access",
  "title": "Drug Pricing Ethics",
  "emoji": "âš–ï¸",
  "color": "#0891B2",
  "description": "Learn Drug Pricing Ethics in one minute.",
  "is_free": false,
  "published": true,
  "story": {
    "hook": {
      "text": "A lifesaving cancer drug costs $100,000 per year. It costs $100 to manufacture. Who decides the price?",
      "visual": "ğŸ’°"
    },
    "buildup": {
      "text": "Pharmaceutical companies set prices based on development costs, patents, and what markets will bear.",
      "visual": "ğŸ“ˆ"
    },
    "discovery": {
      "text": "Patents give 20-year monopolies to incentivize innovationâ€”but can price patients out of lifesaving treatments.",
      "visual": "ğŸ”’"
    },
    "twist": {
      "text": "Many breakthrough drugs were developed using taxpayer-funded researchâ€”then sold back to the public at huge markups.",
      "visual": "ğŸ˜¤"
    },
    "climax": {
      "text": "Balancing innovation incentives with affordable access is one of medicine's most urgent ethical challenges.",
      "visual": "âš–ï¸"
    },
    "punchline": {
      "text": "A cure you can't afford isn't really a cure.",
      "visual": "ğŸ’”"
    }
  },
  "quiz": {
    "question": "Why are drug prices ethically controversial?",
    "options": [
      "Patents allow monopoly pricing that can block patient access",
      "All drugs cost the same amount to manufacture",
      "Pharmaceutical companies never invest in research"
    ],
    "correct": 0
  }
}
